This panel will discuss the real and potential impact of implantable Brain-Computer Interfaces (BCIs) on the preservation of quality of life in late-stage Amyotrophic Lateral Sclerosis (ALS), and the ethical, medical, and financial implications of future clinical implementation of implantable BCIs, with the goal to collect material for a white paper about this theme.
Moderator: Jonathan R. Wolpaw, MD, Director, National Center for Adaptive Neurotechnologies (NCAN)
• Mariska Vansteensel, PhD, Assistant Professor, Department of Neurology and Neurosurgery, University Medical Center Utrecht (The Netherlands)
• Eran Klein, MD, PhD, Assistant Professor, Department of Neurology, Oregon Health and Science University and Affiliate Assistant Professor, Department of Philosophy and Center for Neurotechnology, University of Washington (USA)
• Ghislaine van Thiel, PhD, Associate Professor of Medical Ethics, University Medical Center Utrecht (The Netherlands)
• Michael Gaytant, MD, PhD, Center of Home Mechanical Ventilation, University Medical Center Utrecht (The Netherlands)
• Zachary Simmons, MD, Professor of Neurology and Professor of Humanities, Pennsylvania State University and director of the ALS Clinic and Research Center (USA)
Event Conductor: Christopher M. Lee, PhD, Managing Director, International Association of Accessibility Professionals (IAAP), Chief Learning Officer, G3ict
The webinar is part of NeuroAbilities, the G3ict’s newest dedicated program to explore the current state of assistive solutions based on advanced Neurotechnologies, Brain-Computer Interfaces (BCI) and Artificial Intelligence (AI) enabling persons with disabilities and older persons to better interact with their environment. Visit: https://g3ict.org/research_programs/neuroabilities
Real-time closed captioning will be provided.